BackMEDIROM Healthcare Technologies Overview

MEDIROM Healthcare Technologies Other Current Liabilities

Latest other current liabilities for MRM: $43M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$42.64M
94.24% YoYΔ $-697.61M vs prior year quarter

Peer average

Loading

MEDIROM Healthcare Technologies Other Current Liabilities History

Loading

MEDIROM Healthcare Technologies vs. peers: Other Current Liabilities Comparison

Loading

MEDIROM Healthcare Technologies Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

MEDIROM Healthcare Technologies (MRM) FAQ

As of the most recent data (December 2025), MRM shows a other current liabilities of $43M. That compares with $740M in the prior-year period — down 94.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MRM's other current liabilities is now $43M (was $740M) — a 94.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether MEDIROM Healthcare Technologies is outperforming or lagging.

Tracking MRM's other current liabilities over time shows whether MEDIROM Healthcare Technologies is scaling, shrinking, or reshaping that part of the business. The current reading is $43M That compares with $740M in the prior-year period — down 94.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has MEDIROM Healthcare Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $43M) with ownership activity and broader fundamentals.

MEDIROM Healthcare Technologies's other current liabilities is $43M; compare it with other Consumer Discretionary names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.